LUMIERA HEALTH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | 0.00% |
| 2023 | Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023 | CI |
| 2023 | Lumiera Health Inc. Appoints Mr. Shawn Moniz to the Board of Directors | CI |
Valuation
| Fiscal Period: November | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Capitalization 1 | 13.26 | 9.155 | 5.379 | 2.549 | 0.8498 |
| Enterprise Value (EV) 1 | 12.43 | 9.288 | 4.39 | 2.966 | 2.73 |
| P/E ratio | -6 x | -5.35 x | -1.9 x | -1.52 x | -0.31 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 24.7 x | 18.5 x | 10.7 x | 4.74 x | 1.35 x |
| EV / Revenue | 23.2 x | 18.8 x | 8.71 x | 5.51 x | 4.33 x |
| EV / EBITDA | -27.4 x | -6.82 x | -4.71 x | -1.9 x | -2.21 x |
| EV / FCF | -41.7 x | -31.7 x | 2.83 x | -0.86 x | -3.04 x |
| FCF Yield | -2.4% | -3.15% | 35.4% | -116% | -32.9% |
| Price to Book | 14 x | -25.7 x | -65.9 x | 4.29 x | -0.42 x |
| Nbr of stocks (in thousands) | 63,136 | 63,136 | 97,799 | 169,965 | 169,965 |
| Reference price 2 | 0.2100 | 0.1450 | 0.0550 | 0.0150 | 0.005000 |
| Announcement Date | 3/1/19 | 3/27/20 | 3/11/21 | 3/22/22 | 6/30/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Noviembre | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.1413 | 0.5367 | 0.495 | 0.5042 | 0.5381 | 0.6306 |
| EBITDA 1 | -0.2246 | -0.4531 | -1.363 | -0.9328 | -1.558 | -1.238 |
| EBIT 1 | -0.2269 | -0.4647 | -1.376 | -0.9489 | -1.642 | -1.323 |
| Operating Margin | -160.64% | -86.58% | -278.06% | -188.21% | -305.13% | -209.71% |
| Earnings before Tax (EBT) 1 | -0.2414 | -1.474 | -1.712 | -1.929 | -1.203 | -2.77 |
| Net income 1 | -0.2414 | -1.474 | -1.712 | -1.929 | -1.203 | -2.77 |
| Net margin | -170.93% | -274.7% | -345.9% | -382.54% | -223.62% | -439.28% |
| EPS 2 | -0.006369 | -0.0350 | -0.0271 | -0.0290 | -0.009850 | -0.0163 |
| Free Cash Flow 1 | -0.2169 | -0.2977 | -0.293 | 1.553 | -3.448 | -0.897 |
| FCF margin | -153.52% | -55.48% | -59.19% | 308.05% | -640.67% | -142.23% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 10/31/18 | 3/1/19 | 3/27/20 | 3/11/21 | 3/22/22 | 6/30/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: November | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 0.13 | - | 0.42 | 1.88 |
| Net Cash position 1 | 0.05 | 0.83 | - | 0.99 | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.0981 x | - | -0.2674 x | -1.519 x |
| Free Cash Flow 1 | -0.22 | -0.3 | -0.29 | 1.55 | -3.45 | -0.9 |
| ROE (net income / shareholders' equity) | -143% | -185% | -321% | 1,957% | -471% | 388% |
| ROA (Net income/ Total Assets) | -45.1% | -24.8% | -77.6% | -31.6% | -38% | -68.6% |
| Assets 1 | 0.5356 | 5.94 | 2.206 | 6.107 | 3.164 | 4.038 |
| Book Value Per Share 2 | 0 | 0.0200 | -0.0100 | -0 | 0 | -0.0100 |
| Cash Flow per Share 2 | 0 | 0.0200 | 0 | 0.0200 | 0 | 0 |
| Capex | - | - | - | 0.01 | 0 | 0 |
| Capex / Sales | - | - | - | 1.3% | 0.32% | 0.35% |
| Announcement Date | 10/31/18 | 3/1/19 | 3/27/20 | 3/11/21 | 3/22/22 | 6/30/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 621K | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- NHP.H Stock
- Financials Lumiera Health Inc.
